Compare CRON & QFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRON | QFIN |
|---|---|---|
| Founded | N/A | 2016 |
| Country | Canada | China |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2015 | 2018 |
| Metric | CRON | QFIN |
|---|---|---|
| Price | $3.23 | $6.20 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $14.80 |
| AVG Volume (30 Days) | 757.9K | ★ 1.8M |
| Earning Date | 11-05-2026 | 11-17-2026 |
| Dividend Yield | N/A | ★ 25.59% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $146,587,000.00 | N/A |
| Revenue This Year | $46.73 | N/A |
| Revenue Next Year | $23.43 | N/A |
| P/E Ratio | $26.83 | ★ $2.21 |
| Revenue Growth | ★ 24.63 | N/A |
| 52 Week Low | $2.28 | $5.93 |
| 52 Week High | $3.61 | $27.98 |
| Indicator | CRON | QFIN |
|---|---|---|
| Relative Strength Index (RSI) | 46.27 | 17.76 |
| Support Level | $2.65 | N/A |
| Resistance Level | $3.28 | $14.03 |
| Average True Range (ATR) | 0.09 | 0.25 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 23.03 | 11.75 |
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
Qfin Holdings Inc is engaged in matching individual borrowers with credit demand to a diversified pool of financial institutions with credit to supply through a financial technology platform. It has released large-scale financial credit multimodal benchmark, building a critical bridge between credit AI research and real-world applications.